Eosinophil activation in preterm infants with lung disease

E Berggren Broström1, M Katz-Salamon, J Lundahl

  • 1Department of Pediatrics, Södersjukhuset, Karolinska Institute, Stockholm, Sweden. eva.berggren-brostrom@karolinska.se

Insights

Bronchopulmonary dysplasia (BPD) in preterm infants is linked to eosinophil activation. Eosinophil counts and activity markers were elevated in BPD infants, suggesting a role in disease pathogenesis.

Area of Science:

  • Neonatal Medicine
  • Pulmonology
  • Immunology

Background:

  • Bronchopulmonary dysplasia (BPD) is a significant complication in preterm infants.
  • The precise mechanisms underlying BPD pathogenesis remain incompletely understood.
  • Eosinophils are implicated in various inflammatory lung diseases.

Purpose of the Study:

  • To investigate the role of eosinophils in the pathogenesis of BPD in preterm infants.
  • To compare eosinophil counts and activation markers between preterm infants with BPD, respiratory distress syndrome (RDS), and healthy controls.

Main Methods:

  • Comparative study involving preterm infants with BPD (n=15), RDS (n=13), and healthy controls (n=16).
  • Analysis of venous blood samples for total eosinophil and neutrophil counts.
  • Measurement of eosinophilic cationic protein (ECP) and CD9 levels as markers of eosinophil activation.

Main Results:

  • Significantly higher eosinophil counts were observed in infants with BPD compared to RDS and healthy infants (p=0.03).
  • Elevated ECP levels (p=0.002) and reduced CD9 expression (p=0.01) in BPD infants indicate eosinophil activation.
  • ECP levels correlated positively with oxygen supplementation duration; eosinophil counts decreased after steroid treatment in BPD infants.

Conclusions:

  • Eosinophil activation is associated with bronchopulmonary dysplasia in preterm infants.
  • These findings suggest that eosinophils may play a contributory role in the pathogenesis of BPD.
  • Further research into eosinophil-targeted therapies for BPD is warranted.
Abstract

Related Concept Videos

Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Breathing01:05

Breathing

The process of breathing, inhaling and exhaling, involves the coordinated movement of the chest wall, the lungs, and the muscles that move them. Two muscle groups with important roles in breathing are the diaphragm, located directly below the lungs, and the intercostal muscles, which lie between the ribs. When the diaphragm contracts, it moves downward, increasing the volume of the thoracic cavity and creating more room for the lungs to expand. When the intercostal muscles contract, the ribs...
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.